These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15105956)

  • 41. Advances in environmental and occupational disorders in 2008.
    Bush RK; Peden DB
    J Allergy Clin Immunol; 2009 Mar; 123(3):575-8. PubMed ID: 19281905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molds and mycotoxins in dust from water-damaged homes in New Orleans after hurricane Katrina.
    Bloom E; Grimsley LF; Pehrson C; Lewis J; Larsson L
    Indoor Air; 2009 Apr; 19(2):153-8. PubMed ID: 19191921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxic mold: phantom risk vs science.
    Chapman JA; Terr AI; Jacobs RL; Charlesworth EN; Bardana EJ
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):222-32. PubMed ID: 14533653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molds, mycotoxins, and sick building syndrome.
    Straus DC
    Toxicol Ind Health; 2009; 25(9-10):617-35. PubMed ID: 19854820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Literature on mycotoxins and human health at the time of the ACOEM report.
    Hodgson MJ; Dearborn DG
    Int J Occup Environ Health; 2009; 15(1):115-7. PubMed ID: 19267132
    [No Abstract]   [Full Text] [Related]  

  • 46. Co-occurrence of toxic bacterial and fungal secondary metabolites in moisture-damaged indoor environments.
    Täubel M; Sulyok M; Vishwanath V; Bloom E; Turunen M; Järvi K; Kauhanen E; Krska R; Hyvärinen A; Larsson L; Nevalainen A
    Indoor Air; 2011 Oct; 21(5):368-75. PubMed ID: 21585551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies of sick building syndrome. IV. Mycotoxicosis.
    Assoulin-Daya Y; Leong A; Shoenfeld Y; Gershwin ME
    J Asthma; 2002 May; 39(3):191-201. PubMed ID: 12043850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mold science and conflict of interest.
    Orford RR
    Int J Occup Environ Health; 2009; 15(1):114; author reply 114-5. PubMed ID: 19267131
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of indoor mold concentrations on daily symptom severity of children with asthma and/or rhinitis monosensitized to molds.
    Inal A; Karakoc GB; Altintas DU; Guvenmez HK; Aka Y; Gelisken R; Yilmaz M; Kendirli SG
    J Asthma; 2007 Sep; 44(7):543-6. PubMed ID: 17885857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxic indole alkaloids avrainvillamide and stephacidin B produced by a biocide tolerant indoor mold Aspergillus westerdijkiae.
    Mikkola R; Andersson MA; Hautaniemi M; Salkinoja-Salonen MS
    Toxicon; 2015 Jun; 99():58-67. PubMed ID: 25804991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of molds and mycotoxins in being sick in buildings: neurobehavioral and pulmonary impairment.
    Kilburn KH
    Adv Appl Microbiol; 2004; 55():339-59. PubMed ID: 15350801
    [No Abstract]   [Full Text] [Related]  

  • 52. Are indoor molds causing a new disease?
    Terr AI
    J Allergy Clin Immunol; 2004 Feb; 113(2):221-6. PubMed ID: 14722497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moldy buildings, health of their occupants and fungal prevention.
    Mihinova D; Pieckova E
    Bratisl Lek Listy; 2012; 113(5):314-8. PubMed ID: 22616593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mold remediation in a hospital.
    Lee TG
    Toxicol Ind Health; 2009; 25(9-10):723-30. PubMed ID: 19854823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antifungal Peptides and Proteins to Control Toxigenic Fungi and Mycotoxin Biosynthesis.
    Martínez-Culebras PV; Gandía M; Garrigues S; Marcos JF; Manzanares P
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indoor mold exposure associated with neurobehavioral and pulmonary impairment: a preliminary report.
    Kilburn KH
    Arch Environ Health; 2003 Jul; 58(7):390-8. PubMed ID: 15143851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The concentration of no toxicologic concern (CoNTC) and airborne mycotoxins.
    Hardin BD; Robbins CA; Fallah P; Kelman BJ
    J Toxicol Environ Health A; 2009; 72(9):585-98. PubMed ID: 19296408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preconceptional, prenatal and postnatal exposure to outdoor and indoor environmental factors on allergic diseases/symptoms in preschool children.
    Deng Q; Lu C; Ou C; Chen L; Yuan H
    Chemosphere; 2016 Jun; 152():459-67. PubMed ID: 27003368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
    Campbell AW; Thrasher JD; Madison RA; Vojdani A; Gray MR; Johnson A
    Arch Environ Health; 2003 Aug; 58(8):464-74. PubMed ID: 15259425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interstitial lung disease due to domestic moulds].
    Blanc AL; Delhaes L; Copin MC; Stach B; Faivre JB; Wallaert B
    Rev Mal Respir; 2011 Sep; 28(7):913-8. PubMed ID: 21943538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.